Gene therapy and Biomarker for Diabetes

Biomarkers are useful tools for research into type 1 diabetes (T1D) for a number of purposes, including elucidation of disease pathogenesis, risk prediction, and therapeutic monitoring. Susceptibility genes and islet autoantibodies are currently the most useful biomarkers for T1D risk prediction, progress, opportunities, challenges, and future directions in the development of T1D biomarkers.

 

    Related Conference of Gene therapy and Biomarker for Diabetes

    January 28-29, 2026

    24th World Congress on Nutrition and Food Chemistry

    Zurich, Switzerland
    April 02-03, 2026

    7th European Food Chemistry Congress

    Geneva, Switzerland
    May 25-26, 2026

    9th European Food Science Congress

    Paris, France
    May 25-26, 2026

    20th International Conference on Food Microbiology

    Zurich, Switzerland
    May 25-26, 2026

    35th World Conference on Food and Beverages

    Zurich, Switzerland
    June 17-18, 2026

    7th Global summit on Agriculture & Organic farming

    Aix-en-Provence, France
    October 08-09, 2026

    30th International Conference on Food and Nutrition

    Rome, Italy
    October 29-30, 2026

    5th International Conference on Agroecology and Organic farming

    Aix-en-Provence, France

    Gene therapy and Biomarker for Diabetes Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in